Tranexamic acid (TXA) is a potent antifibrinolytic with documented efficacy in reducing blood
loss and allogeneic red blood cell transfusion in several clinical settings. With a growing …

Tranexamic acid (TXA) is a lysine analog that exhibits an anti-fibrinolytic effect by directly
preventing the activation of plasminogen as well as inhibiting activated plasmin from …

Abstract Objective The French Society of Anesthesiology and Intensive Care Medicine
[Société Française d'Anesthésie et de Réanimation (SFAR)] aimed at providing guidelines …

Unicompartmental knee osteoarthritis (UKOA) is the early stage of knee joint degeneration,
which is characterized by unicompartmental degeneration and mostly occurs in medial …

Background Tranexamic acid (TXA) is an antifibrinolytic agent applied in orthopedic surgery
and has been proven to reduce post-surgery infection rates. We previously showed that TXA …

Purpose The purpose of this study was to prospectively evaluate the clinical and radiological
results of double level osteotomy (distal femoral lateral closed wedge and proximal tibial …

Purpose Aim of this systematic review was to evaluate the literature regarding the effect of
tranexamic acid (TXA) on the outcome after knee osteotomy. Methods A systematic literature …

Background A comprehensive review of the current evidence investigating the potential
therapeutic effects of tranexamic acid (TXA) and its safety in foot and ankle surgery is …

This study aimed to evaluate the efficiency and safety of tranexamic acid for blood
management during high tibial osteotomy (HTO). A systematic search was conducted in …

Methods: One hundred eight tibia osteotomies performed during 2019 to 2021 were
evaluated, representing all tibia osteotomies except situations of existing infection. A …